May 13, 2014

Valeant Pharmaceuticals on Monday announced that certain of its subsidiaries have entered into settlement agreements with Actavis related to Actavis' generic versions of Tiazac XC.

March 26, 2014

Actavis and Valeant Pharmaceuticals International announced that the Food and Drug Administration approved the new drug application for Metronidazole 1.3% vaginal gel. The antibiotic is used for the treatment of bacterial vaginosis, an infection caused by an imbalance in the normal bacteria of vagina.

January 31, 2014

Valeant Pharmaceuticals International announced that it received approval from the Food and Drug Administration for Retin-A Micro (tretinoin) gel microsphere 0.08%.

January 23, 2014

Valeant Pharmaceuticals International on Thursday announced the expiration of the tender offer by a subsidiary of Valeant Pharmaceuticals International to purchase all of the outstanding shares of Solta Medical for $2.92 per share in cash, without interest (less any applicable withholding taxes).

December 16, 2013

Valeant Pharmaceuticals International will acquire Solta Medical for about $250 million, Valeant said Monday.

November 15, 2013

The Food and Drug Administration has approved a new drug for fungal infections of the skin made by Valeant Pharmaceuticals International, the drug maker said Friday.

October 2, 2013

Drug maker Valeant Pharmaceuticals International is joining an effort to oppose domestic violence, the company said Wednesday.

August 6, 2013

Valeant Pharmaceuticals announced it has completed its previously announced acquisition of Bausch + Lomb.

March 27, 2012

Neptune Technologies and Bioressources on Tuesday announced that Denver Broncos EVP football operations and retired star quarterback John Elway has signed on as a spokesman for the company's Neptune Krill Oil brand.

April 13, 2011

Neptune Technologies & Bioressources last week announced that Bayer HealthCare’s consumer care division formally has launched its Arctic Wonder proprietary Neptune Krill Oil in the United States following a successful market test.

November 15, 2010

Generic drug maker Actavis has filed for approval of a generic version of an antidepressant...